Literature DB >> 16996541

Mutation impact on dysferlin inferred from database analysis and computer-based structural predictions.

Christian Therrien1, Dubravka Dodig, George Karpati, Michael Sinnreich.   

Abstract

Dysferlin is a large sarcolemmal protein implicated in the repair of surface membrane tears in muscle cells. Mutations in dysferlin result in limb girdle muscular dystrophy type 2B and Miyoshi myopathy. Using a cDNA based approach we identified eight new pathogenic dysferlin alleles. To better understand how missense mutations could lead to reduced or absent dysferlin expression levels, we mapped missense mutations from our own and from published databases (n=55) to the secondary protein structure of dysferlin, deduced by computerized structural prediction tools. We found the protein to be very sensitive to the alteration of residues that were predicted to be buried inside the protein structure. We identified seven putative C2 domains, one more than commonly reported, of both type I and type II topology in dysferlin. Missense mutations often affected those structures as well as residues that were highly conserved between members of the ferlin family. Thus, alteration of structurally important residues in dysferlin could lead to improper folding and degradation of the mutant protein.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16996541     DOI: 10.1016/j.jns.2006.07.004

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  16 in total

Review 1.  Ferlins: regulators of vesicle fusion for auditory neurotransmission, receptor trafficking and membrane repair.

Authors:  Angela Lek; Frances J Evesson; R Bryan Sutton; Kathryn N North; Sandra T Cooper
Journal:  Traffic       Date:  2011-09-06       Impact factor: 6.215

2.  Proteasomal inhibition restores biological function of mis-sense mutated dysferlin in patient-derived muscle cells.

Authors:  Bilal A Azakir; Sabrina Di Fulvio; Jochen Kinter; Michael Sinnreich
Journal:  J Biol Chem       Date:  2012-02-08       Impact factor: 5.157

3.  Modular dispensability of dysferlin C2 domains reveals rational design for mini-dysferlin molecules.

Authors:  Bilal A Azakir; Sabrina Di Fulvio; Steven Salomon; Marielle Brockhoff; Christian Therrien; Michael Sinnreich
Journal:  J Biol Chem       Date:  2012-06-26       Impact factor: 5.157

4.  Endocytic recycling proteins EHD1 and EHD2 interact with fer-1-like-5 (Fer1L5) and mediate myoblast fusion.

Authors:  Avery D Posey; Peter Pytel; Konstantina Gardikiotes; Alexis R Demonbreun; Mark Rainey; Manju George; Hamid Band; Elizabeth M McNally
Journal:  J Biol Chem       Date:  2010-12-22       Impact factor: 5.157

Review 5.  Translational research and therapeutic perspectives in dysferlinopathies.

Authors:  Florian Barthélémy; Nicolas Wein; Martin Krahn; Nicolas Lévy; Marc Bartoli
Journal:  Mol Med       Date:  2011-05-06       Impact factor: 6.354

6.  Characterization of zebrafish dysferlin by morpholino knockdown.

Authors:  Genri Kawahara; Peter R Serafini; Jennifer A Myers; Matthew S Alexander; Louis M Kunkel
Journal:  Biochem Biophys Res Commun       Date:  2011-08-27       Impact factor: 3.575

7.  Dysferlin interacts with tubulin and microtubules in mouse skeletal muscle.

Authors:  Bilal A Azakir; Sabrina Di Fulvio; Christian Therrien; Michael Sinnreich
Journal:  PLoS One       Date:  2010-04-12       Impact factor: 3.240

8.  Therapeutic exon skipping for dysferlinopathies?

Authors:  Annemieke Aartsma-Rus; Kavita H K Singh; Ivo F A C Fokkema; Ieke B Ginjaar; Gert-Jan van Ommen; Johan T den Dunnen; Silvère M van der Maarel
Journal:  Eur J Hum Genet       Date:  2010-02-10       Impact factor: 4.246

9.  Phylogenetic analysis of ferlin genes reveals ancient eukaryotic origins.

Authors:  Angela Lek; Monkol Lek; Kathryn N North; Sandra T Cooper
Journal:  BMC Evol Biol       Date:  2010-07-29       Impact factor: 3.260

Review 10.  Dysferlin and muscle membrane repair.

Authors:  Renzhi Han; Kevin P Campbell
Journal:  Curr Opin Cell Biol       Date:  2007-07-26       Impact factor: 8.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.